...
首页> 外文期刊>Cardiovascular Research >Alteration in flow (shear stress)-induced remodelling in rat resistance arteries with aging: improvement by a treatment with hydralazine.
【24h】

Alteration in flow (shear stress)-induced remodelling in rat resistance arteries with aging: improvement by a treatment with hydralazine.

机译:鼠抗性动脉中血流(剪切应力)诱导的重塑随年龄的变化:用肼屈嗪治疗可改善这种情况。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

AIMS: The link between aging and vascular diseases remains unclear, especially in resistance arteries. As a decreased vasodilator capacity of the endothelium is usually described in aging, we hypothesized that arteriolar remodelling in response to a chronic increase in blood flow might be altered. In addition, we tested the capacity of a vasodilator treatment with hydralazine to restore remodelling, as we have previously shown that hydralazine has a potent effect on the process. METHODS AND RESULTS: Mesenteric resistance arteries (350 microm diameter) from 3- and 24-month-old rats were exposed to high blood flow (HF) and normal blood flow (NF), for 2 weeks by sequential ligating second-order arteries in vivo. In HF arteries, diameter increased by 21% when intraluminal pressure was 100 mmHg, in association with a rise in superoxide production in young rats. On the other hand, both diameter and superoxide levels failed to increase in old rats. Hydralazine restored HF-induced remodelling in old rats in association with an increased superoxide production and a decreased superoxide dismutase (SOD) expression. The SOD-mimetic 4-hydroxy-2,2,6,6-tetramethyl piperidinoxyl (TEMPOL) prevented the effect of hydralazine on the arterial diameter. In old rats, hydralazine increased the arterial diameter in HF arteries without increasing eNOS expression. Furthermore, hydralazine also restored HF remodelling in eNOS knockout mice. CONCLUSION: Thus, flow remodelling in resistance arteries failed to occur in aging but it could be restored by hydralazine via a reactive oxygen species-dependent mechanism. These findings may have serious pathophysiological consequences in situations requiring flow-dependent remodelling such as ischaemic and metabolic diseases, more frequent in the elderly.
机译:目的:衰老与血管疾病之间的联系仍然不清楚,尤其是在阻力动脉中。由于通常在衰老中描述了内皮血管舒张能力下降,因此我们假设响应慢性血流增加的小动脉重构可能会改变。此外,我们测试了使用肼苯哒嗪进行血管扩张剂治疗的能力,以恢复重塑,因为我们之前已经证明了肼苯哒嗪对该过程具有有效作用。方法和结果:通过依次结扎二阶动脉,将3个月和24个月大大鼠的肠系膜阻力动脉(直径350微米)暴露于高血流量(HF)和正常血流量(NF)下2周。体内。在腔内压力为100 mmHg时,HF动脉的直径增加了21%,这与幼鼠中超氧化物的产生增加有关。另一方面,老年大鼠的直径和超氧化物水平均未增加。肼屈嗪可恢复老年大鼠HF诱导的重塑,并伴有超氧化物生成增加和超氧化物歧化酶(SOD)表达降低。模拟SOD的4-羟基-2,2,6,6-四甲基哌啶氧基(TEMPOL)预防了肼屈嗪对动脉直径的影响。在老年大鼠中,肼屈嗪可增加HF动脉的动脉直径,而不会增加eNOS的表达。此外,肼苯哒嗪还恢复了eNOS基因敲除小鼠的HF重塑。结论:在衰老过程中,阻力动脉的血流重建没有发生,但是可以通过肼苯哒嗪通过依赖活性氧的机制来恢复。这些发现在需要血流依赖性重塑的情况下可能会产生严重的病理生理后果,例如缺血性和代谢性疾病,老年人更为常见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号